In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Luisa LutzInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.ORCID 0009-0009-7438-3781 Ipek EkemenInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.
Diana RaspInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.
Annika DietzInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.
Lisa WenzelInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.
Jakob TriebelInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.ORCID 0000-0002-1989-8645 Thomas BertschInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.
Gundula Schulze-TanzilInstitute of Anatomy and Cell Biology, Paracelsus Medical University, Nuremberg, Germany.ORCID 0000-0002-9807-9532 Bernd NeumannInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.ORCID 0000-0002-3580-2105 Joerg SteinmannInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.ORCID 0000-0002-3181-3667 Ralph BertramInstitute of Laboratory Medicine and Infectious Diseases, Paracelsus Medical Private University, Nuremberg General Hospital, Nuremberg, Germany.ORCID 0000-0003-0654-6381 Funding
Manfred-Roth-Stiftung
6 · The paper itselfAbstract
IMPORTANCE: Hypervirulent
Indexed as
Gene Expression Regulation, BacterialKlebsiella pneumoniaeTetracyclineAnimalsAnti-Bacterial AgentsBacterial ProteinsHumansKlebsiella InfectionsMothsPlasmidsPromoter Regions, GeneticRepressor ProteinsVirulenceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsRepressor ProteinsTetracyclineVirulence FactorsGalleria mellonellagene regulationhypervirulent Klebsiella pneumoniaeinducible expressionpathogenicitytetracycline
Identifiers
PMID42439532
PMCPMC13436325
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390